Trial | NCT01367587  Report issue

Title

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone
Safety and Gastrointestinal Effects of Multiple-Dosed Intravenous Methylnaltrexone in Healthy Human Volunteers

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    12
This study evaluates the safety of multiple doses of IV MNTX in normal healthy adults.
Study Started
Apr 30
2002
Primary Completion
Jul 31
2002
Study Completion
Jul 31
2002
Last Update
Nov 27
2019

Drug IV Methylnaltrexone

Arm 1 Experimental

Criteria 

Inclusion Criteria:

Must be male or non-pregnant female volunteers
Must be 18 to 65 yrs of age
Must have no significant active disease states

Exclusion Criteria:

History or current evidence of disease (cardiovascular, respiratory, endocrine, renal, hepatic, hematological, or psychiatric)
Illicit drug users
Subjects who received an experimental new drug in the past 30 days
Subjects with any laboratory findings outside normal limits
No Results Posted